NCT00196599View on ClinicalTrials.gov

Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

February 28, 1999

Study Completion Date

September 30, 2004

Conditions
HIV InfectionsAntiretroviral Naive
Interventions
DRUG

emtricitabine, FTC (drug)

DRUG

didanosine, ddI (drug)

DRUG

efavirenz (drug)

Sponsors
All Listed Sponsors
collaborator

Triangle Pharmaceuticals

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Dupont Applied Biosciences

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV